Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 203,331 | 156,719 | 452,049 | 131,612 | 226,577 |
| Cost of Goods | 7,957 | 2,338 | 4,151 | 1,463 | 3,829 |
| Gross Profit | 195,374 | 154,381 | 447,898 | 130,149 | 222,748 |
| Operating Expenses | 410,789 | 314,901 | 308,233 | 277,472 | 334,398 |
| Operating Income | -214,458 | -160,182 | 139,816 | -146,860 | -110,821 |
| Interest Expense | 22,688 | 22,164 | 22,762 | 22,930 | 22,861 |
| Other Income | 9,229 | 53,953 | 6,477 | 22,968 | 26,644 |
| Pre-tax Income | -227,917 | -128,393 | 123,531 | -146,822 | -107,038 |
| Income Tax | 1,477 | 213 | -20 | 116 | -2,689 |
| Net Income Continuous | -229,394 | -128,606 | 123,551 | -146,938 | -104,349 |
| Net Income | $-229,394 | $-128,606 | $123,551 | $-146,938 | $-104,349 |
| EPS Basic Total Ops | -1.43 | -0.80 | 0.78 | -0.93 | -0.66 |
| EPS Basic Continuous Ops | -1.43 | -0.81 | 0.78 | -0.93 | -0.66 |
| EPS Diluted Total Ops | -1.35 | -0.80 | 0.70 | -0.93 | -0.66 |
| EPS Diluted Continuous Ops | -1.33 | -0.81 | 0.68 | -0.93 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -1.41 | -0.80 | 0.70 | -0.93 | -0.66 |
| EBITDA(a) | $-210,821 | $-159,113 | $141,046 | $-146,929 | $-113,330 |